Product Information

CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0662 per EA under NDC 70752010710. Its NADAC has been published 268 times since May 12, 2021.

CYPROHEPTADINE 4 MG TABLET

CYPROHEPTADINE HYDROCHLORIDE
$0.0662per EA

Strength

4 mg/1

NDC

70752010710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212491

On Market Since

2/24/2021

Price Statistics

The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 268 times since May 12, 2021, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0662 per EA
All-time high$0.1349 (Jun 16, 2021)
All-time low$0.0644 (Apr 22, 2026)
52-week high$0.0836
52-week low$0.0644
Median price$0.0874
Average price$0.0869
Largest weekly change-25.5% (Jun 23, 2021)
Weeks tracked268
Tracking sinceMay 12, 2021

Price History

1W

0.0%

1M

+1.3%

3M

-0.0%

6M

+1.9%

1Y

-20.8%

3Y

-31.9%

5Y

-34.1%

All

-50.7%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Quagen Pharmaceuticals LLC, is $0.0662 per EA (NDC 70752010710), effective Jun 24, 2026.

How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 50.7%. It has been tracked across 268 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?

Since May 12, 2021, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.1349 (Jun 16, 2021), with a median of $0.0874 per EA.

Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?

4 NADAC-published products share the same active ingredient, strength, and dosage form as CYPROHEPTADINE 4 MG TABLET, but none are currently priced below it.

Who manufactures CYPROHEPTADINE 4 MG TABLET?

CYPROHEPTADINE 4 MG TABLET (NDC 70752010710) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.